FDA Inspection 1235581 — Scinopharm Taiwan, Ltd.
The FDA completed an inspection of Scinopharm Taiwan, Ltd. on March 21, 2024 in Tainan City. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Tainan City (Taiwan)